CLASS II Device recall · Reported 6 Jul 2022 · FDA Enforcement Report

TEG 5000 Functional Fibrinogen Reagent recalled by Haemonetics

Haemonetics is recalling TEG 5000 Functional Fibrinogen Reagent, distributed nationwide in the US. The recall was initiated on 26 Apr 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: (01)20812747018095 All lots are affected.
Quantity recalled3933 kits (US); 2429 kits (OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1310-2022
FDA event ID
90323
Recalling firm
Haemonetics, Boston, MA
Classification
Class II
Status
Terminated
Recall initiated
26 Apr 2022
FDA classified
30 Jun 2022
Reported
6 Jul 2022
Type
Voluntary: Firm initiated
Reason category
Lead & Heavy Metals

Timeline

26 Apr 2022Recall initiated by company
30 Jun 2022Classified by FDA+65 days
6 Jul 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to a shift in the citrated blood reference range for a normal population, the ranges stated in the IFU are changing. If the clinician relies solely on affected results in comparison to the normal donor reference range, it could lead to misdiagnosis and incorrect treatment or failure to treat.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034

Where it was distributed

Domestic distribution US Nationwide.

Nationwide

Questions about this recall

Is TEG 5000 Functional Fibrinogen Reagent recalled?

Yes. Haemonetics recalled TEG 5000 Functional Fibrinogen Reagent on 26 Apr 2022. The recall is Class II and its status is Terminated. Recall number Z-1310-2022.

Why was it recalled?

Due to a shift in the citrated blood reference range for a normal population, the ranges stated in the IFU are changing. If the clinician relies solely on affected results in comparison to the normal donor reference range, it could lead to misdiagnosis and incorrect treatment or failure to treat.

Which lots are affected?

UDI-DI: (01)20812747018095 All lots are affected.

Where was it sold?

Domestic distribution US Nationwide.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Haemonetics

All 31

Other Test Kits & Diagnostics recalls

All 2,656